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Abstract. The paper is devoted to mathematical modelling of erythropoiesis, production of red
blood cells in the bone marrow. We discuss intra-cellular regulatory networks which determine
self-renewal and differentiation of erythroid progenitors. In the case of excessive self-renewal,
immature cells can fill the bone marrow resulting in the development of leukemia. We introduce
a parameter characterizing the strength of mutation. Depending on its value, leukemia will or
will not develop. The simplest model of treatment of acute myeloid leukemia with chemother-
apy allows us to determine the conditions of successful treatment or of its failure. We show that
insufficient treatment can worsen the situation. In some cases curing may not be possible even
without resistance to treatment. Modelling presented in this work is based on ordinary differential
equations, reaction-diffusion systems and individual based approach.
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1. Introduction to erythropoiesis
Erythropoiesis is the process of production and regulation of red blood cells. It is part of a more
general process, hematopoiesis, which allows the formation of all blood cells: white cells, platelets,
and red blood cells. All blood cells originate from pluripotent stem cells, called hematopoietic
stem cells, which have unique ability to differentiate in one of the three blood lineages [12, 43].
1Corresponding author. E-mail: crauste@math.univ-lyon1.fr
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Hematopoiesis occurs in the bone marrow where cells proliferate, differentiate, and ultimately
mature cells enter the bloodstream.
During erythropoiesis, cells undergo several divisions, with immature (stem cells, progenitors)
and mature stages (reticulocytes, erythrocytes), to finally release cells that will be devoted to oxy-
gen transport in blood. Erythropoiesis is based on a balance between erythroid cell self-renewal
(the ability for a mother cell to produce daughter cells with the same maturity level [42]), dif-
ferentiation (the production of daughter cells more mature than the mother cell) and apoptosis
(programmed cell death [37]). Self-renewal is usually considered to be a property of hematopoi-
etic stem cells only, yet recent studies [21, 30] showed that erythroid progenitors can self-renew,
especially in stress situations. In erythropoiesis, mature cells almost only differentiate, so only
progenitors (immature cells) are concerned with self-renewal, differentiation and apoptosis.
These three processes are regulated by numerous intracellular proteins and growth factors.
Among all growth factors, glucocorticoids (lipophilic hormones) and erythropoietin (glucopro-
tein) play particular roles. Glucocorticoids have been shown to regulate erythroid progenitor self-
renewal in stress erythropoiesis [7, 34]. Erythropoietin has been proved to act at various stages
in erythroid progenitor maturation, and especially to inhibit erythroid progenitor apoptosis [23].
Among the proteins regulating erythroid cell fate, some key proteins have already been identified.
We can cite c-Kit, the protein associated with the stem cell factor (SCF) [28], proteins from the
JAK family [38], etc. Recently, Rubiolo et al. [34] identified two proteins, Erk and Fas, as key
proteins involved in two antagonist loops acting for erythroid progenitor self-renewal and differ-
entiation/apoptosis, respectively.
Mathematical modelling of hematopoietic cell dynamics has attracted much attention since the
end of the 1970’s. A pioneering work was proposed by Mackey [26] in 1978. This model describes
hematopoietic stem cell dynamics using a system of delay differential equations. The approach
proposed in [26] has been the basis for many works devoted to the description of oscillatory be-
haviors within hematopoietic systems. For instance, in [9] Bernard et al. focused on the white
blood cell production to bring an explanation to oscillatory behaviors observed in patients with
cyclical neutropenia. See also Adimy et al. [4]. In [32] Pujo-Menjouet and Mackey used a similar
model to investigate the appearance of oscillations in blood cell count within patients with chronic
myelogenous leukemia. Causes of periodic chronic myelogenous leukemia were also investigated
by Adimy et al. [2, 3]. A global model of hematopoietic cell dynamics has been proposed by Colijn
and Mackey [14, 15] in 2005, and has been applied to the study of cyclical neutropenia and peri-
odic chronic myelogenous leukemia. Recently, models incorporating the action of growth factors
on hematopoietic cell dynamics have been considered, see for instance Adimy et al. [1, 5], and
the references therein. Mathematical models of hematopoiesis applied to neutropenia have also
been recently proposed by Vainstein et al. [39, 40], using pharmacodynamics-pharmacokinetics
approaches. Mechanisms of leukemias have been investigated by Panetta et al. [31], Shoshat et al.
[36], and the references therein.
In 1995, Be´lair et al. [8] considered a model of erythropoiesis with a feedback on stem cells
from red blood cells mediated by erythropoietin. In [1], Adimy and Crauste enriched the Mackey’s
model [26] by adjusting erythropoietin effect on the apoptosis rate of erythroid progenitors, in
agreement with Koury and Bondurant [23]. More recently, Crauste et al. [16] and Demin et
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al. [19] proposed new models of erythropoiesis focusing on progenitor dynamics and taking into
account self-renewal ability of erythroid progenitors, contrary to what had been done in all the
above mentioned works.
In this paper, we investigate erythroid cell dynamics by means of a reaction-diffusion system
describing cell dynamics and a system of ordinary differential equations describing concentrations
of intra-cellular proteins involved in the regulation of self-renewal, differentiation and apoptosis.
This model is used to focus on erythroleukemia, a cancer of red blood cells characterized by a
rapid increase of immature and abnormal erythroid progenitors in the bone marrow and the blood.
Erythroleukemia, or Di Guglielmo syndrome [27], represents in the United States about 5% of de
novo acute myeloid leukemias, and between 20% and 30% of secondary leukemias.
Spatial cell distribution can play an important role in hematopoietic cell dynamics because
mature cells (reticulocytes) increase differentiation of immature cells when they are close to each
other [18]. Moreover, cells push each other in the bone marrow creating pressure difference. It
determines their motion and sorting out to blood vessels. Finally, when cell concentration becomes
sufficiently high, they can exchange signals which decrease their proliferation and increase apop-
tosis. Spatial models of hematopoiesis have been previously used, in particular by Ducrot and
Volpert [20] to model the development of myelogenous leukemia.
The modelling of the intra-cellular regulatory network is similar to the one described in Roeder
and Glauche [33], where the authors considered the interaction between two transcription factors,
GATA-1 and PU.1, involved in lineage commitment, and concluded the existence of bistability in
their model, i.e. the existence of two stable fixed points, each one corresponding to promotion of
one of both lineages. It has also been studied by Huang et al. [22]. Demin et al. [19] proposed a
similar model for intra-cellular erythropoiesis regulation.
We consider that erythroid progenitors have the ability to self-renew. This assumption has been
used recently by Crauste et al. [16]. Authors concluded that adding self-renewing capacity to ery-
throid progenitors allows better reproduction of experimental data describing stress erythropoiesis
(severe anemia). Several erythroid progenitor maturation levels, depending on the maturity, are
considered. Two proteins, Erk and Fas, are assumed to be determining for choice between self-
renewal, differentiation and apoptosis of erythroid progenitors [34]. The interaction between them
is supposed to have a bistable behavior [19, 33].
The intra-cellular regulatory network is described and analyzed in Section 2. It is later used,
in Section 4, in order to determine the rates of self-renewal and differentiation of erythroid pro-
genitors. Mechanisms of cell motion are discussed in Section 3 and modelled with the individual
based approach (cell dynamics software [10]). We show the existence of random motion due to
cell division and of directed motion due to cell pressure. The contribution of each of these two
factors can be different. In particular, if the cell density is low, then their random motion prevails
over directed motion. In this case we can use reaction-diffusion systems of equations in order to
describe the evolution of cell populations.
In Section 4 we model normal and leukemic erythropoiesis with reaction-diffusion systems.
This analysis allows us to introduce the notion of strength of mutation. If this parameter exceeds a
critical value then leukemia will develop. If the mutation is not strong enough, then the influx of
normal cells from the stem cell compartment will not allow leukemia to develop. It is interesting
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to note that suppression of leukemia by the influx of normal cells has already been observed,
though with another mechanism: in [10, 20] it is related to directed (convective) cell motion. A
simple model of leukemia treatment with chemotherapy is proposed and shows that treatment can
obviously lead to curing, yet in some cases an inappropriate drug dose can worsen the situation.
2. Intracellular regulation network
Rubiolo et al. [34] recently investigated regulatory mechanisms of erythroid differentiation. They
identified key proteins involved in erythroid progenitor self-renewal and those involved in ery-
throid progenitor differentiation and apoptosis (see Figure 1). For each cell fate, self-renewal and
differentiation/apoptosis, they gave a regulatory pathway made of three proteins: Raf-1, Mek and
Erk for the self-renewal loop, Fas, ASK-1 and JNK/p38 for differentiation/apoptosis. A source
term for Raf-1 activation appears in their scheme, glucocorticoids (lipophilic hormones), however
other source terms do not appear in this scheme and should be taken into account: erythropoietin
(glucoprotein) is known to activate erythroid progenitor proliferation and inhibit their apoptosis
[23], Fas-ligand (membrane protein) activates Fas [18], for instance.
Figure 1: Intracellular regulatory network, adapted from [34]. Two self-sustaining loops competing
with each other are presented. Activation of Raf-1 - MEK - Erk reaction cascade induces erythroid
cell self-renewal, whereas Fas - ASK1 - JNK/p38 cascade initiates cell differentiation which in
presence of low erythropoietin levels activates caspase cascade that results in cell apoptosis.
Two proteins appear of particular importance in this process: Erk and Fas. The former is part of
an auto-activating self-renewing loop and inhibits the differentiation/apoptosis regulatory pathway,
the latter induces differentiation and apoptosis and inhibits Erk. We focus on these two proteins
and describe their interactions by means of a system of ordinary differential equations.
Denote by α and γ the external sources of Erk and Fas activator, respectively. For instance, α
stands for the activation by glucocorticoids and erythropoietin, and γ by Fas-ligand. Let β denotes
the rate of Erk self-activation. This self-activation is supposed to be nonlinear, with a sensitivity
k ≥ 1.
Due to limited resources, we assume there is a maximal value that limits the production of Erk,
denoted by E0. One may notice that a maximal value limiting the production of Fas could also be
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introduced, yet thanks to the structure of the second equation in (2.1) a simple change of notations
would enable to get a similar equation. Hence such an assumption is not used.
Let denote by a and d respectively Erk and Fas degradation rates. Also denote by b the rate of
Erk expression suppression, due to the action of Fas (see Figure 1). This rate then depends on Fas
concentration, denoted by F , and this dependence is supposed to be linear. Moreover, in agreement
with mass action law, we assume b is also proportional to the concentration of Erk, denoted by E.
The Erk-dependent suppression rate of Fas expression is denoted by c.
Then we obtain the following system that describes a simplified version of the regulatory net-
work presented in Figure 1 based on Erk and Fas concentrations,
dE
dt
= (α+ βEk)(E0 − E)− aE − bEF := Φ(α,E, F ),
dF
dt
= γ − cE − dF := Ψ(γ,E, F ),
(2.1)
where coefficients a, b, c and d are positive.
In the following, we assume α > 0 and γ > 0, and we focus on the existence of stationary
points of (2.1).
The zero lines of the right-hand sides of these equations are given by the formula
F =
(α + βEk)(E0 − E)
bE
− a
b
, cE + dF = γ.
Depending on the parameters, system (2.1) has from one to three stationary points. The case of
three stationary points is shown in Figure 2. The points A and C are stable nodes, the point B is
a saddle. The point A corresponds to high levels of Fas and low levels of Erk, whereas the point
C corresponds to low levels of Fas and high levels of Erk. Hence, the point A is associated with
erythroid cell differentiation or apoptosis, the point C with erythroid cell self-renewal.
The basins of attraction of the points A and C are separated by the separatrix of the point
B. If the initial condition is chosen in a random way on the plane (E,F ), then the probability
for the trajectory to go to the point A or to the point C depends on the areas of their basins of
attraction. Let us denote these probabilities by pA and pC , respectively. It can be easily verified
that pA increases with the increase of γ and decreases with the increase of α. Moreover,
pA =
{
0, if γ ≤ γ0,
1, if γ ≥ γ1,
where γ0 and γ1 are some given values, γ0 < γ1, which depend on α. We note that pA + pC = 1.
Hence, if γ is sufficiently large the erythroid cell will undergo differentiation or apoptosis, whereas
if γ is sufficiently small it will self-renew.
Before ending this section, let us briefly concentrate ourselves on the case α = 0.
When α = 0, (2.1) has a stationary point given by (E,F ) = (0, γ/d). It describes an absence
of Erk and a saturation of Fas. Other stationary points are solutions of
F =
β
b
Ek−1(E0 − E)− a
b
and cE + dF = γ. (2.2)
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Figure 2: Phase plane of system (2.1).
One can then easily check that (2.2) may have from 0 up to 2 solutions. These stationary solutions
have the same behavior as the stationary solutions obtained above for α > 0, two of them are
stable, whereas the third one (located, geometrically, between the other two) is unstable.
Dynamics of the intra-cellular network regulating cell fate (self-renewal, differentiation and
death by apoptosis) have been discussed above. The next section is devoted to the nature of cell
motion, in particular the use of reaction-diffusion systems for the description of erythroid progen-
itor dynamics will be dealt with.
3. Cell division and displacement in individual based modelling
Spatial cell distribution in the bone marrow should be taken into account in order to specify the con-
ditions of leukemia development. This distribution is closely related to cell division and displace-
ment. In this section we will investigate both cell division and displacement with the individual
based modelling approach. We will also use it to explain the origin of random cell motion due to
division. This will justify the usage of reaction-diffusion systems in the next section. Simulations
will be performed using the software “Cell dynamics”, version “Soft sphere model”, presented in
details in Bessonov et al. [10].
We briefly recall the basis of the individual based model used in the software “Cell dynamics”.
Let us consider a system of particles on the plane with the coordinates x1, . . . , xN , where xi is a
vector with two components. Each particle moves according to the equation
x¨i + νx˙i +
∑
j 6=i
f(rij) = 0, (3.1)
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where the second term in the left-hand side of this equation describes the friction of the particle by
the medium, the last term represents the force acting on the particle by all other particles. This is
one of possible models in the approach called dissipative particle dynamics [10]. The force f(rij)
between the i-th and the j-th particle depends on the distance rij between them. In molecular
dynamics this is the Van der Waals force, which is nonlocal and usually described by the Lennard-
Jones potential. In the case of cell dynamics, the force between two particles is nonzero only when
they touch each other, that is when the distance between the centers of the spherical particles is
less than the sum of their radii.
Equation (3.1) allows us to determine the position of each cell in time. In addition, the process
of cell division, which changes the number of cells and the forces acting between them, must be
specified. This is done hereafter.
3.1. Cell division
When hematopoietic cells in the bone marrow divide, they push each other resulting in their dis-
placement. This mechanism determines motion of immature red blood cells, which are the most
represented cells in the bone marrow. Therefore, in order to study cell motion, we need to begin
with cell division.
When a cell divides, it is replaced by two other cells. If we neglect the mechanical interaction
with other cells, then the center of mass of the body composed by the two daughter cells does not
change in comparison with the center of mass of the mother cell. Hence, after each division, each
daughter cell is shifted with respect to its mother cell. Figure 3 shows several first consecutive
divisions simulated with the software “Cell dynamics”, version “Soft sphere model”. Cell size and
the frequency of division are given as parameters of the model.
Figure 3: Successive cell divisions simulated with the software “Cell dynamics”, version “Soft
sphere model”. Every division gives birth to two daughter cells (green for a self-renewing division,
purple for differentiating division). The direction of division is not specified.
There is one more parameter which should be specified in order to describe cell division: the
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direction of division, that is the direction of the straight line connecting the centers of the new
cells. In some cases, the direction of division can be determined by the position of the mother cell
with respect to the surrounding cells. In particular, this can be the case in embryogenesis or in
plant growth. However, in the case of hematopoiesis, we can assume that this direction is arbitrary.
Therefore the angle of the straight line connecting the centers with respect to the x-axis is chosen
in a random way with a uniform distribution.
Let now focus on cell motion. Consider the following division process A → A + B (Figure
3) under the assumptions formulated above. After each division the cell A gives one cell, which is
identical to itself (self-renewal), and another cell which is different (differentiation). Hence, there
will always be one cell of the type A and a growing number of cells B. After each division the cell
A moves in a random direction at the distance equal to its radius. This means that the cell A moves
along the plane in a random way. In the case where there are many such cells and we can consider
them as a continuous medium, this motion becomes similar to diffusion and can be described in a
similar way. We will discuss this question in more detail in the next section.
Each cell defined in the individual-based model must be able to divide, change its type, or die
(either by apoptosis or necrosis). Hence probabilities for such events are provided by the user, for
each type of cell defined. These probabilities are determined by intra-cellular regulatory networks.
In the case of erythroid progenitors they are discussed in Section 2.
In the example shown in Figure 4 (left), there is one stem cell (green) that divides in two cells at
each division, one cell is identical (this is self-renewal) and the other cell is of another type (red). In
turn, the red cell can self-renew with the probability 0.57, differentiate with the probability 0.39,
or die by apoptosis with the probability 0.04 (this probability does not appear on Figure 4, it is
obtained from the two other probabilities). In the first case, it divides giving two cells identical to
itself. In the second case, it gives two different cells (violet). If the cell dies, it is removed from the
computational domain. Red cells can also mutate with the probability 0.001. When this happens, a
mutated cell (yellow) appears. Its properties are different in comparison with the original cell (red).
It self-renews with the probability 0.7, differentiates with the probability 0.3, and does not die by
apoptosis. These assumptions correspond, for instance, to properties of malignant cells. Their
self-renewal ability is greater than for normal cells, while differentiation and apoptosis abilities are
lower (or absent). Therefore, we can expect that after some time malignant cells will appear and
will take over normal cells. It is numerically observed that malignant cells push out normal cells
and gradually fill the whole computational domain (Figure 4, right). This replacement corresponds
to reaction-diffusion waves discussed in Section 4, Theorem 1. Cell division occurs according to
the algorithm described above, presented in Figure 3.
3.2. Cell displacement
There are various mechanisms of cell displacement in the bone marrow. We discuss here random
cell motion, which is to some extent similar to diffusion, and directed cell motion, similar to
convection. Since biological cells are macroscopical objects, the usual Fickian diffusion is not
applicable for them. However they can move in a random way due to division.
Let us discuss the motion of a single dividing cell when it is surrounded by other cells. Obvi-
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Figure 4: Simulation obtained with the software “Cell dynamics”. Left: Properties of the different
cells involved in the computations are listed, as self-renewing (same color), differentiating (dif-
ferent color) and mutation (yellow) probabilities. Right: Computational domain, filled with cells
defined on the left panel.
ously, cells push each other and create a preferential direction of motion. It is easier for a cell to
move in the direction where there are less cells. In order to study this phenomenon, we consider
the following numerical experiment. The cell A is placed at the bottom of an empty rectangular
box (Figure 5, left). It divides reproducing itself and some other cells which fill the box. These
latter cells do not divide and do not move unless they are pushed by other cells. What will be the
position of the cell A in time? If it moves in a random way, its distance from the initial position
will grow proportionally to
√
t (with random perturbations). However, when there are many other
cells around it, they will influence its motion pushing it to the direction where cell concentration is
lower. If we introduce pressure, that is the force exerted by cells on the unit surface, then, similar
to Darcy’s law, cell velocity will be determined by pressure gradient [13]. It can be verified on
model examples that the cell will move in this case with a constant speed, that is its displacement
will be proportional to t.
We can vary the ratio of the directed and random motion. In order to do this, let us consider
the division scheme in the form A → A + B + 2C and assume that the cells A and B have the
same radius, the radius of the cell C is twice less, the cell B is located on one side of the cell A
after the division, and the cells C on the diametrically opposite side. The cell A is shown in yellow
in Figure 5, B and C in blue. Clearly, such a cell division is not realistic from the biological
point of view. We consider it in order to explain the mechanisms of cell motion. We use here the
advantage of mathematical modelling, which allows us to consider idealized models, in order to
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Figure 5: Trajectory and displacement of a cell A dividing according to the process A→ A+B+
2C. Left: Rectangular domain, center: cell trajectory, right: cell displacement.
study a symmetric division where the center of the cell A does not shift after cell division, and
various asymmetric divisions where this center displaces due to division. In the real biological
situation, division is asymmetric. We will see below that this results in a random cell motion.
However if cell density is sufficiently high, convective cell motion becomes also important. To
study it more precisely and independently of the random motion, we need to consider a symmetric
division.
With the division scheme shown in Figure 5, the center of the cell A before and after the
division remains at the same place. In fact, we consider here not the center of mass of the system
of cells but its geometrical center. Hence, cell division in this case does not provide random motion.
Figure 5 shows the cell trajectory and its displacement from the initial position. We can see that its
displacement is close to a linear function. Therefore, it is a directed motion with a weak random
component.
Figure 6: Trajectory and displacement of a cellA dividing according to the processA→ A+B+C,
where B and A have the same radius, and the radius of C equals one half of the radius of A. Left:
Rectangular domain, center: cell trajectory, right: cell displacement.
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Figure 6 shows another scheme of cell division, A→ A+B+C, where B and C are from the
opposite sides of A. Since the radius rC of C is twice less than the radius rB of B, then the center
of the cell A moves at rC/2 after each division. The cell displacement remains practically linear.
However its trajectory essentially changes in comparison with the previous case. The projection
of the cell speed on the vertical direction remains the same since it is determined by the frequency
of its division. In other words, by the rate with which it fills the box with other cells. However,
its local mobility becomes higher because of the increased random motion. The cell motion has
two components: small random displacements and large scale sinusoidal motion from one side to
another and upwards. This horizontal motion of the cell is caused by the pressure difference. Since
the box is sufficiently large, the cell first fills one side, then another side of the box. Its increased
mobility makes it more sensitive to the pressure difference.
Figure 7: Cell trajectory (left) and displacement (right) in the case of a strong random component.
If we increase even more the random component of the cell motion by appropriately choosing
division scheme, then the directed component of its motion is not visible any more (Figure 7).
Another parameter which determines the relative contribution of the random and directed compo-
nents of the cell motion is their concentration. If it is low, then mechanical interaction with the
surrounding cells will be negligible.
In the next section we model the evolution of cell populations by reaction-diffusion equations.
We take into account their random motion described by the diffusion-terms but not their directed
motion. Directed or convective motion should be taken into account if the density of cell population
is sufficiently high. In this case it would be described by reaction-diffusion equations coupled with
fluid dynamics in a porous medium. Such a model has been studied in previous works [10, 20].
We note finally that the diffusion coefficient depends on the cell adhesion to the extracellular
matrix. In particular, leukemic cells have a weaker adhesion and, consequently, a bigger diffusion
coefficient.
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4. Approximation of fast intra-cellular regulation
4.1. Normal erythropoiesis
Consider several erythroid progenitor sub-populations denoted by P1, . . . , Pn (see Demin et al.
[19] for more details). Each of them consists of identical cells with given rates of self-renewal si,
differentiation di and apoptosis ai, i = 1, . . . , n. As discussed in Section 2, these rates and their
dependence on the parameters are determined by the Erk/Fas regulatory system (see Figure 1). In
the framework of the model described in Section 2, they are determined by the basins of attraction
of the corresponding stationary points.
Evolution of these population densities is described by the ordinary differential system of equa-
tions 
dP1
dt
= H + (s1 − d1 − a1)P1,
dPi
dt
= (si − di − ai)Pi + 2di−1Pi−1, i = 2, . . . , n,
(4.1)
where H denotes a constant flux of hematopoietic stem cells differentiating in erythroid progen-
itors, the coefficients si, di and ai depend on the values of the concentrations of intra-cellular
proteins Erk and Fas, Ei and Fi. These concentrations are regulated by intra-cellular networks (see
Section 2). In this section we will not take into account the external control feedback by hormones
(glucocorticoids or erythropoietin) discussed in Section 2. Hence, the source term α in system
(2.1) is assumed to be constant. Fas-ligand, the main external source for Fas activation is produced
by mature cells [18], hence we assume γ, in (2.1), is a function of Pj , j = 1, . . . , n. Consequently,
the protein concentrations are governed by the equations (cf. [19])
dEi
dt
= Φ(α,Ei, Fi),
dFi
dt
= Ψ
(∑n
j=1 µijPj, Ei, Fi
)
,
(4.2)
where the functions Φ and Ψ are defined in (2.1), and µij are constant parameters accounting for
the weight of mature cell populations in the production of Fas-ligand.
We now introduce spatial cell distribution. We consider a one-dimensional problem with the
space variable x and assume cells can move in space in a random way. This motion can be de-
scribed by diffusion (see Section 3). The intra-cellular concentrations Ei and Fi are supposed to
be the same for all cells in the i-th population, therefore they do not depend on the space variable,
but can depend on time.
We also take into account a limitation of cell proliferation when cell density exceeds some
threshold level, by means of a chemical cell interaction. Let P0 be the maximal cell density. Then
system (4.1) can be rewritten in order to take into account both diffusion and the dependence of
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cell proliferation (self-renewal and differentiation) on P0 − P¯ , where P¯ =
∑n
i=1 Pi,
∂P1
∂t
= D
∂2P1
∂x2
+H + (s1 − d1)P1(P0 − P¯ )− a1P1,
∂Pi
∂t
= D
∂2Pi
∂x2
+ (si − di)Pi(P0 − P¯ )− aiPi + 2di−1Pi−1(P0 − P¯ ), i = 2, . . . , n.
(4.3)
In order to be able to analyze the model, we first assume intra-cellular reactions are fast in the
time scale related to cell motion. Then, instead of system (4.2), we can consider the stationary
equations
Φ(α,Ei, Fi) = 0, Ψ
(
n∑
j=1
µijPj, Ei, Fi
)
= 0. (4.4)
Therefore, Ei and Fi can be expressed as functions of Pj , j = 1, . . . , n. As a consequence,
coefficients si, di, ai in (4.1) also become functions of Pj .
System (4.3) and (4.4) describes erythroid progenitor dynamics in normal erythropoiesis under
the assumption of fast intra-cellular reactions. Consider first the case of a single cell population
P1. Then system (4.3) is reduced to the first equation where P¯ = P1:
∂P1
∂t
= D
∂2P1
∂x2
+H + (s1 − d1)P1(P0 − a1
s1 − d1 − P1). (4.5)
Equation
H + (s1 − d1)P1(P0 − a1
s1 − d1 − P1) = 0
has a unique positive solution P1 = P ∗1 if s1 − d1 > 0. It is a globally asymptotically stable
stationary solution of equation (4.5), that satisfies P ∗1 ≥ max{0, P0 − a1/(s1 − d1)}.
If P0 > a1/(s1 − d1), then P ∗1 ≥ P0 − a1/(s1 − d1), and P ∗1 is positive even if H = 0.
This means that even in the absence of hematopoietic stem cells, erythroid progenitors keep a
positive concentration due to self-sustained proliferation. This case seems to be unrealistic from
the biological point of view. Therefore, we will assume in what follows P0 ≤ a1/(s1 − d1).
In the next section, we introduce a population of leukemic cells and investigate the dynamics
of the model. In particular, we focus on the existence of a leukemic equilibrium.
4.2. Erythroleukemia
Consider two cell lineages, normal and mutated. The lineage of mutated cells will differ by the
rates of self-renewal, differentiation and apoptosis. Denote by Pi cells from the normal lineage
and by Qi cells from the mutated lineage. Both of them are described by the same model (4.3) as
in the previous section. However, we should take here into account that the total number of cells
include both lineages,
P¯ = P1 + · · ·+ Pn +Q1 + · · ·+Qn.
In what follows we restrict ourselves to the case where each of these two lineages consists of
a single cell type. This is equivalent to the assumption that we neglect in the previous equality all
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cell densities except for P1 and Q1. Then equations for P1 and Q1 become independent of other
equations and can be written in the form:
∂P
∂t
= DP
∂2P
∂x2
+H + (s− d)P (P0 − P −Q)− aP,
∂Q
∂t
= DQ
∂2Q
∂x2
+ (sm − dm)Q(P0 − P −Q)− amQ,
(4.6)
where the subscripts are omitted for simplicity of notation, and sm, dm, am denote the rates of
self-renewal, differentiation and apoptosis of mutated cells, respectively. In particular, since there
is only one generation of erythroid progenitors, denoted by P , the influence of progenitor densities
on the activation of Fas is neglected, so that (4.4) becomes
Φ(α,E, F ) = 0, Ψ(γ,E, F ) = 0,
with α > 0 and γ > 0 constant. Consequently E and F no longer depend on P and, similarly,
the different rates do not depend on cell densities. This assumption has then strong consequences,
yet it allows drawing comprehensive conclusions on the existence of a leukemic equilibrium and
treatment of the disease (see below).
The constant sourceH is absent in the second equation of (4.6) because it is assumed in the case
of erythroleukemia there is no permanent influx of mutated cells from the stem cell compartment.
Different assumptions could of course be considered.
4.2.1. Existence of a Leukemic Equilibrium
In order to analyze reaction-diffusion system (4.6), we first consider the system without diffusion,
dP
dt
= H + (s− d)P (P0 − P −Q)− aP,
dQ
dt
= (sm − dm)Q(P0 − P −Q)− amQ,
(4.7)
and we assume s− d > 0, sm − dm > 0, and am/(sm − dm) < P0 < a/(s− d). The assumption
am/(sm − dm) < P0 ensures the possibility to have a leukemic equilibrium (see (4.8)), as shown
below.
Zero lines of the right-hand side of (4.7) are given by the equalities
H + kP (−b− P −Q) = 0, kmQ(bm − P −Q) = 0, (4.8)
where
k = s− d, km = sm − dm, b = −P0 + a
k
, bm = P0 − am
km
.
According to the above assumptions, all parameters, k, km, b and bm are positive.
From the first equation in (4.8),
Q = −b− P + H
kP
, (4.9)
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and from the second equation
Q = 0 or Q = bm − P. (4.10)
Figure 8: Graphical solution of system (4.9)–(4.10). Case 1 corresponds to the existence of two
stationary points, A and B, the case 3 to the existence of only one stationary point, B. In case 2,
the points A and B have the same location.
System (4.9)–(4.10) can have one or two stationary points (Figure 8). If we put Q = 0 in (4.9),
and denote by P ∗ the positive solution of this equation, then we find
P ∗ =
b
2
(√
1 +
4H
kb2
− 1
)
.
The stationary solution (P,Q) = (P ∗, 0) always exists.
On the other hand, from (4.9) and the second equation in (4.10), we obtain
P ∗m +Q
∗
m = −b+
H
kP ∗m
and P ∗m +Q
∗
m = bm.
If bm > P ∗, then we have the case 1 in Figure 8. There exist two stationary points: A with the
coordinates (P ∗m, Q
∗
m), and B with the coordinates (P
∗, 0). If bm < P ∗, then we have the case 3 in
Figure 8, there exists a unique stationary point B = (P ∗, 0). It follows that leukemia may develop
only if bm > P ∗.
Condition bm > P ∗ can be written as
bm(bm + b) >
H
k
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or equivalently (
µ− P0k
a
)
(µ− 1) > Hk
a2
, (4.11)
where
µ =
am
a
k
km
=
am
a
s− d
sm − dm . (4.12)
We call the inverse parameter 1/µ the strength of mutation. If a malignant mutation decreases the
rate of apoptosis and differentiation and increases the rate of proliferation, then µ < 1. This means
that the strength of mutation is greater than 1.
We recall that the assumption b > 0 implies that P0k/a < 1. Moreover, from (4.12) and the
assumption bm > 0, one deduces µ < P0k/a. Consequently, the left-hand side of (4.11) is positive.
Furthermore, it is straightforward that inequality (4.11) is satisfied if and only if
P0 >
H
a
. (4.13)
This condition means that (4.11) is true for µ = 0. Indeed, the set of values of µ satisfying (4.11)
is an interval in the form [0, µ∗) with µ∗ < P0k/a < 1. If (4.13) is not satisfied, then leukemia will
not develop, independently of the strength of mutation. This occurs if the influx of normal cells
from the stem cell compartment is sufficiently large.
If (4.11) is satisfied, that is the mutation is sufficiently strong and the influx is not strong
enough, then system (4.7) has two stationary points A and B (Figure 8). It can be verified that A is
stable while B is unstable. This means that the disease will develop. The values of the concentra-
tions P ∗m and Q
∗
m in the leukemic equilibrium depend on µ. In particular, the concentration Q
∗
m of
malignant cells can be rather low if µ is close to the critical value. If (4.11) is not satisfied (weak
mutation or strong influx), then there exists a unique stable stationary point B, which corresponds
to the disease free situation.
Before turning to the treatment investigation, let us go back to the reaction-diffusion system
(4.6). The analysis of the ordinary differential system of equations (4.7) allows us to do some
conclusions about the behavior of solutions of (4.6). More precisely, classical results on monotone
systems allow to conclude to the existence of a travelling wave providing a transition from the
unstable disease free equilibrium B to the leukemic equilibrium A, when (4.11) is satisfied. The
existence and stability of travelling waves for monostable monotone reaction-diffusion systems are
well known [41]. The existence result is stated in the next theorem.
Theorem 1. Let condition (4.11) be satisfied. Then the endemic equilibrium (P ∗m, Q∗m) of system
(4.6) considered on the whole axis is globally asymptotically stable in the sense that any solution
with the initial condition (P0(x), Q0(x)), where P0(x) ≥ ², Q0(x) ≥ ², ² is a positive constant,
converges uniformly to (P,Q) = (P ∗m, Q
∗
m) as t → ∞. The disease free solution (P ∗, 0) is
unstable.
Moreover there exists a minimal speed c0 such that for all speeds c ≥ c0 there exist travelling
wave solutions of system (4.6), that is solutions of the form P (x, t) = p(x−ct), Q(x, t) = q(x−ct).
The functions p(x) and q(x) are monotone with respect to x and satisfy the system
DP p
′′ + cp′ +H + (s− d)P (P0 − P −Q)− aP = 0,
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DQ q
′′ + cq′ + (sm − dm)Q(P0 − P −Q)− amQ = 0
and the conditions at infinity:
p(−∞) = P ∗m, q(−∞) = Q∗m, p(+∞) = P ∗, q(+∞) = 0.
For c < c0 such solutions do not exist.
The proof of the theorem is based on the reduction of system (4.6) to a monotone system and on
the application of the comparison principle. The interested reader may refer to [41] for details.
It is known that the appearance of malignant cells is due to several rare consecutive mutations.
Once this event occurs, malignant cells start proliferating. If malignant cells appear then they
persist and spread in the whole bone marrow in the form of a travelling wave. Their existence is
stated in Theorem 1.
In the following, we investigate potential treatment of leukemia that is, from a modeling point
of view, how can we make the leukemic equilibrium disappear?
4.2.2. Treatment
Treatment of acute myeloid leukemia by chemotherapy, in particular by Ara-C (cytosine arabi-
noside), decreases cell proliferation and increases apoptosis. In the simplest case, in order to
model treatment of erythroleukemia, we can assume proliferation and apoptosis rates of normal
and malignant cells are proportional to some parameter τ characterizing the intensity of treatment:
sτ = s/τ, dτ = d/τ, aτ = τa, s
τ
m = sm/τ, d
τ
m = dm/τ, a
τ
m = τam,
and Hτ = H/τ . Here τ ≥ 1, so in the absence of treatment the coefficients are not modified.
Moreover, an increase of τ increases apoptosis rates while it decreases self-renewal and differenti-
ation rates, for both normal and leukemic cells, and it decreases the stem cell influx. Under these
assumptions, the parameter µ defined in (4.12) does not depend on τ . Treatment will be successful
if for a given µ there exists τ such that(
µ− P0k
aτ 2
)
(µ− 1) ≤ Hk
a2τ 4
. (4.14)
In particular, we can take τ =
√
P0k/(aµ) for which the left-hand side of this inequality vanishes.
Consequently, there exists τ > 1 such that (4.14) holds true. In fact, we can be more accurate.
Define the function
f(τ) =
Hk
a2τ 4
−
(
µ− P0k
aτ 2
)
(µ− 1), τ ≥ 1,
and suppose f(1) < 0, that is the leukemic equilibrium exists without treatment ((4.11) holds true).
Then one easily obtains
f ′(τ) = 2
k
aτ 3
[
(1− µ)P0 − 2 H
aτ 2
]
.
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Since µ < 1, then f ′(τ) > 0 if and only if
τ >
√
2
H
a(1− µ)P0 := τ˜ .
One can note that either τ˜ ≤ 1 or τ˜ > 1, depending on the parameters. Consequently, if τ˜ ≤ 1, the
function f is strictly increasing. It crosses the x-axis for a given τ and
lim
τ→∞
f(τ) = µ(1− µ) > 0.
For a sufficiently large drug dose, the treatment is then successful. If τ˜ > 1, then the function f
first decreases from f(1) < 0, until τ = τ˜ , then f increases, crosses the x-axis and reaches its
upper limit (mentioned above). Hence, the treatment will also be successful, yet for 1 ≤ τ ≤ τ˜ the
treatment worsens the disease (in fact, even for τ larger than τ˜ , but not too large).
If we consider Hτ in the form
Hτ = H
τ − τ1
1− τ1 , τ1 > 1,
which takes into account that intensive chemotherapy kills all stem cells (τ = τ1), then instead of
(4.14) we have (
µ− P0k
aτ 2
)
(µ− 1) ≤ Hk(τ − τ1)
a2τ 3(1− τ1) , τ ∈ [1, τ1]. (4.15)
Let define
g(τ) =
Hk(τ − τ1)
a2τ 3(1− τ1) −
(
µ− P0k
aτ 2
)
(µ− 1), τ ∈ [1, τ1],
with g(1) < 0, to ensure the existence of the leukemic equilibrium in the absence of treatment.
Simple computations lead to
g′(τ) =
k
aτ 3
[
2(1− µ)P0 + H
a(1− τ1)
(
3
τ1
τ
− 2
)]
.
One can note that, since τ ≤ τ1 then 3τ1/τ − 2 > 0, and g′(τ) > 0 if and only if
τ >
3τ1
2
[
H
a
(1− µ)(τ1 − 1)P0 + 1
] := τ¯ .
Hence, similarly to what we previously concluded for function f , the function g can either be
increasing (if τ¯ ≤ 1), or first decreases from g(1) < 0, until it reaches τ¯ , then provided that τ¯ < τ1
it increases up to g(τ1). We focus on the second case. One can note that
g(τ1) = −
(
µ− P0k
aτ 21
)
(µ− 1)
and can be either negative if µτ 21 < P0k/a, or positive if µτ
2
1 > P0k/a. Thus, various cases can
occur: First, if τ¯ > τ1 then the function g is decreasing on the interval [1, τ1] and treatment only
worsens the disease. Second, if τ¯ < τ1 and g(τ1) < 0, then the treatment can worsen the disease,
and whatever the administered drug dose the treatment can not cure the disease. Finally, if τ¯ < τ1
and g(τ1) > 0 then treatment can worsen the disease (small doses), but eventually the treatment
can cure the disease. This last situation is similar to the above situation, obtained when Hτ = H/τ .
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5. Discussion
The aim of this work was twofold. First, we derived and justified mathematical models of erythro-
poiesis. Often models of cell populations are semi-empiric and based on some intuitive assump-
tions, which seem in agreement with biological observations. We attempted to give here some
more rigorous justification of one of such assumptions about cell displacement. Although there
are different mechanisms of cell motion in the bone marrow, we did not discuss here biologically
active mechanisms such as chemotaxis but concentrated only on pure mechanical cell interaction.
Since new cells appear due to proliferation, cells push each other creating random motion, which
can be described by diffusion, and directed motion determined by pressure difference. We carried
out some analysis of this motion with individual based modelling. Though the results seem to be
convincing, much should be done yet in this direction to have a sufficiently precise description of
cell motion in terms of continuum mechanics.
Another important point of the model is related to intra-cellular regulatory networks which
determine cell behavior. In the case of erythroid progenitors studied in this work we specified the
probabilities of their self-renewal, differentiation and apoptosis. Their values are crucial from the
point of view of the evolution of cell population. We used them in the reaction-diffusion model
and in cell dynamics modelling.
The second aim of this work was related to the analysis of these models in normal and patholog-
ical cases. In particular, if self-renewal is greater than it should be while differentiation and apopto-
sis are less, hemostasis can be unbalanced resulting in malfunctioning of the whole hematopoietic
system. This can be related to malignant mutations. We introduced the parameter, which we
called the strength of mutation, which shows whether leukemia will develop or not. In the case of
strong mutations, a second, leukemic equilibrium appears. The normal equilibrium still exists but
it becomes unstable.
We modelled treatment of leukemia by chemotherapy, considering its action on the rates of
proliferation and apoptosis. In the case of acute myeloid leukemia, chemotherapy kills proliferating
cells, both normal and leukemic. If it kills all leukemic cells, then it should also kill all normal
cells. If some leukemic cells are not killed, this can result in relapse. Why then can treatment be
successful and what can cause its failure?
The development of leukemia is determined by the competition of normal and malignant cells
for space. Malignant cells are more aggressive in the sense that they proliferate more and die
less. The disadvantage of normal cells can be compensated by their influx from the stem cell
compartment. The success or failure of treatment in the framework of our model depends on the
action of chemotherapy on normal stem cells. The analysis of the model showed that different
situations are possible. If normal stem cells are not strongly influenced, then treatment can be
successful. This is in agreement with medical observations that normal stem cells are more resistant
to Ara-C, the main chemotherapeutic agent. On the other hand, insufficient treatment can promote
leukemic cells and worsen the situation. This can happen because treatment kills cells and liberates
place for new cells. Since leukemic cells proliferate more, they can then gain space. If normal stem
cells are strongly influenced by chemotherapy, it is possible that treatment fails whatever the drug
dose.
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We are aware that the model considered in this work is incomplete. We did not take into
account deliberately some of the factors such as the influence of certain hormones on erythroid
progenitors (erythropoietin, glucocorticoids), pharmaco-kinetics of chemotherapy, resistance to
chemotherapy and so on. Moreover, although we presented a rather complex model of erythroid
progenitor dynamics (a system of reaction-diffusion equations coupled to a system of nonlinear
ordinary differential equations describing regulatory intracellular protein network), we analyzed a
simplified version of the model, in order to be able to obtain clear and understandable results. We
began this study with the most simple model in order to reveal its basic properties. More complete
models will be studied in subsequent works, including in particular confrontation to experimental
data for leukemia treatment.
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